Premium
Microfluidic Tissue Model for Live Cell Screening
Author(s) -
Lee Philip J.,
Gaige Terry A.,
Ghorashian Navid,
Hung Paul J.
Publication year - 2007
Publication title -
biotechnology progress
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.572
H-Index - 129
eISSN - 1520-6033
pISSN - 8756-7938
DOI - 10.1021/bp070053l
Subject(s) - microfluidics , fluorescence microscope , cell culture , hela , paclitaxel , spheroid , biomedical engineering , cell , chemistry , cancer cell , biophysics , microbiology and biotechnology , biology , nanotechnology , fluorescence , materials science , cancer , biochemistry , medicine , physics , quantum mechanics , genetics
We have developed a microfluidic platform modeled after the physiologic microcirculation for multiplexed tissue‐like culture and high‐throughput analysis. Each microfabricated culture unit consisted of three functional components: a 50 μm wide cell culture pocket, an artificial endothelial barrier with 2 μm pores, and a nutrient transport channel. This configuration enabled a high density of cancer cells to be maintained for over 1 week in a solid tumor‐like morphology when fed with continuous flow. The microfluidic chip contained 16 parallel units for “flow cell” based experiments where live cells were exposed to a soluble factor and analyzed via fluorescence microscopy or flow‐through biochemistry. Each fluidically independent tissue unit contained ∼500 cells fed with a continuous flow of 10 nL/min. As a demonstration, the toxicity profile of the anti‐cancer drug paclitaxel was collected on HeLa cells cultured in the microfluidic format and compared with a 384‐well dish for up to 5 days of continuous drug exposure.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom